A dual institution real-world study of avelumab for advanced Merkel cell carcinoma

被引：0
|
作者：
Miller, David Michael
Wright, Kayla
Silk, Ann W.
Thakuria, Manisha
Shalhout, Sophia
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Massachusetts Eye & Ear, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Harvard Med Sch, Boston, MA USA
[5] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
    Levy, Sonja
    Aarts, Maureen J. B.
    Eskens, Ferry A. L. M.
    Keymeulen, Kristien B. M., I
    Been, Lukas B.
    Grunhagen, Dirk
    van Akkooi, Alexander
    Jalving, Mathilde
    Tesselaar, Margot E. T.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [2] Avelumab for Advanced Merkel Cell Carcinoma: Global Real-World Data on Patient Response and Survival
    Lohray, Rishabh
    Verma, Kritin K.
    Wang, Leo L.
    Haynes, Dylan
    Lewis, Daniel J.
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2023, 14 : 149 - 154
  • [3] Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in Israel
    Averbuch, Itamar
    Stoff, Ronen
    Miodovnik, Mor
    Fennig, Shlomit
    Bar-Sela, Gil
    Yakobson, Alexander
    Daliot, Jonathan
    Asher, Natan
    Fenig, Eyal
    CANCER MEDICINE, 2023, 12 (11): : 12065 - 12070
  • [4] Real-world clinical outcomes with first-line avelumab in locally advanced/metastatic Merkel cell carcinoma in the USA: SPEAR-Merkel
    Cowey, Charles Lance
    Liu, Frank X.
    Kim, Ruth
    Boyd, Marley
    Fulcher, Nicole
    Krulewicz, Stan
    Kasturi, Vijay
    Bhanegaonkar, Abhijeet
    FUTURE ONCOLOGY, 2021, 17 (18) : 2339 - 2350
  • [5] Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
    Bhatia, Shailender
    Nghiem, Paul
    Veeranki, S. Phani
    Vanegas, Alejandro
    Lachance, Kristina
    Tachiki, Lisa
    Chiu, Kevin
    Boller, Emily
    Bharmal, Murtuza
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [6] REAL-WORLD CLINICAL OUTCOMES AMONG PATIENTS WITH ADVANCED MERKEL CELL CARCINOMA TREATED WITH AVELUMAB IN ACADEMIC MEDICAL CENTERS IN THE UNITED STATES
    Bhatia, Shailender
    Nghiem, Paul
    Veeranki, S. Phani
    Vanegas, Alejandro
    Lachance, Kristina
    Tachiki, Lisa
    Chiu, Kevin
    Boller, Emily
    Bharmal, Murtuza
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A658 - A658
  • [7] Avelumab in the Treatment of Advanced Merkel Cell Carcinoma: A Systematic Review
    Sharma, Ajay N.
    Shah, Karishma S.
    Sharma, Aditi A.
    Yu, Siegrid S.
    DERMATOLOGIC SURGERY, 2024, 50 (05) : 407 - 411
  • [8] Avelumab for advanced Merkel cell carcinoma in the Netherlands: A nationwide survey
    Levy, S.
    Aarts, M. J. B.
    Eskens, F. A.
    Keymeulen, K.
    Been, L.
    Grunhagen, D. J.
    van Akkooi, A. C. J.
    Jalving, M.
    Tesselaar, M. E. T.
    ANNALS OF ONCOLOGY, 2019, 30 : 537 - +
  • [9] Avelumab for Advanced Merkel Cell Carcinoma in the Netherlands; A Nationwide Survey
    Levy, S.
    Aarts, M. J. B.
    Eskens, F.
    Keymeulen, K. B. M., I
    Been, L. B.
    GrUnhagen, D. J.
    van Akkooi, A. C. J.
    Jalving, M.
    Tesselaar, M.
    NEUROENDOCRINOLOGY, 2020, 110 : 232 - 232
  • [10] A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
    Yamazaki, N.
    Kiyohara, Y.
    Sato, M.
    Endo, S.
    Song, B.
    Tanaka, Y.
    Kambe, A.
    Sato, Y.
    Uhara, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1601 - S1602
12345